MBS8400231 | Anti-IL-17alpha (Ixekizumab); Humanized Antibody

Anti-IL-17alpha (Ixekizumab); Humanized Antibody | MBS8400231 | Mybiosource

Product Short Name: [IL-17alpha]

Product Name Synonyme: [LY 2439821; LY-2439821; LY2439821; IL17a; IL17; CTLA8; IL-17; CTLA-8; IL-17A]

Other Names: N/A

Product Gene Name: [IL-17alpha]

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG4; kappa

Clone: N/A

Host: Human

Reactivity: Human

Specificity: The biosimilar is a humanized monoclonal antibody used for the treatment of autoimmune diseases. The antibody specifically targets IL-17alpha and inhibits IL-17alpha mediated inflammatory responses. The original drug is approved by the FDA to treat psoriasis and psoriatic arthritis

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A